Hence, overcoming the immunosuppressive mechanisms driven by the hypoxic TME may be an effective approach to elicit durable anti‐tumour immunity and improve the responses of combined PD‐1/PD‐L1 blockade and radiotherapy. Here, CD274 is linked to neoplasm.